194 related articles for article (PubMed ID: 28811127)
1. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
Sandhu H; Cooper S; Hussain A; Mee C; Maddock H
Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity.
Cooper SL; Sandhu H; Hussain A; Mee C; Maddock H
Toxicology; 2018 Feb; 394():72-83. PubMed ID: 29248607
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.
Auchampach JA; Rizvi A; Qiu Y; Tang XL; Maldonado C; Teschner S; Bolli R
Circ Res; 1997 Jun; 80(6):800-9. PubMed ID: 9168782
[TBL] [Abstract][Full Text] [Related]
5. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
Mlejnek P; Dolezel P; Frydrych I
J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
[TBL] [Abstract][Full Text] [Related]
6. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
7. Ageing alters the severity of Sunitinib-induced cardiotoxicity: Investigating the mitogen activated kinase kinase 7 pathway association.
Cooper S; Sandhu H; Hussain A; Mee C; Maddock H
Toxicology; 2019 Jan; 411():49-59. PubMed ID: 30393206
[TBL] [Abstract][Full Text] [Related]
8. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
Hussain A; Gharanei AM; Nagra AS; Maddock HL
Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
[TBL] [Abstract][Full Text] [Related]
9. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
10. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
[TBL] [Abstract][Full Text] [Related]
11. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA.
Lasley RD; Narayan P; Jahania MS; Partin EL; Kraft KR; Mentzer RM
Am J Physiol; 1999 Jun; 276(6):H2076-84. PubMed ID: 10362690
[TBL] [Abstract][Full Text] [Related]
12. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.
Galvao J; Elvas F; Martins T; Cordeiro MF; Ambrósio AF; Santiago AR
Exp Eye Res; 2015 Nov; 140():65-74. PubMed ID: 26297614
[TBL] [Abstract][Full Text] [Related]
14. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart.
Hochhauser E; Kaminski O; Shalom H; Leshem D; Shneyvays V; Shainberg A; Vidne BA
Antioxid Redox Signal; 2004 Apr; 6(2):335-44. PubMed ID: 15025935
[TBL] [Abstract][Full Text] [Related]
15. A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.
Stambaugh K; Jacobson KA; Jiang JL; Liang BT
Am J Physiol; 1997 Jul; 273(1 Pt 2):H501-5. PubMed ID: 9249524
[TBL] [Abstract][Full Text] [Related]
16. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
Kim GD; Oh J; Jeong LS; Lee SK
Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P; Dolezel P
Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
[TBL] [Abstract][Full Text] [Related]
18. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
Tian Y; Marshall M; French BA; Linden J; Yang Z
Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
Yuan K; Bai GY; Park WH; Kim SZ; Kim SH
Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091
[TBL] [Abstract][Full Text] [Related]
20. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]